Metraipolis › archive › dc_be61713f9d2e

Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42682597
DOI
10.3389/fphar.2026.1895503
License (as archived)
solo-consultazione
Archived
2026-10-08T09:45:50.362Z
SHA-256 of the archived text
adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd
Stable URL of this page
https://metraipolis.com/documento/dc_be61713f9d2e

How to cite

Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597 — Europe PMC (en), https://europepmc.org/article/MED/42682597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be61713f9d2e (Metraipolis archive dc_be61713f9d2e, sha256 adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd)
BibTeX
@misc{dcbe61713f9d2e,
  title = {Differences in adverse drug reactions between GnRH antagonists and agonists in the treatment of prostate cancer: a retrospective analysis using real-world data — Europe PMC PMID:42682597},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42682597},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be61713f9d2e; sha256 adf7e379b45ca70442bdfb1bafe3da252a50c950217aceacd8b05554ad0073dd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42682597. Agents can read the archived copy with the MCP tool read_document.